Quick Takeaways
- ADAGE CAPITAL PARTNERS GP, L.L.C. filed SCHEDULE 13G/A for Compass Therapeutics, Inc. Common stock, par value $0.0001 per share (CMPX).
- Disclosed ownership: 4.4%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"ADAGE CAPITAL PARTNERS GP, L.L.C. disclosed 4.4% ownership in Compass Therapeutics, Inc. Common stock, par value $0.0001 per share (CMPX) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 4.4% | 5,994,810 | 0 | 5,994,810 | /s/ Robert Atchinson | By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member | |
| Adage Capital Partners GP, L.L.C. | 0% | 0 | 0 | 0 | /s/ Robert Atchinson | By: Adage Capital Advisors, L.L.C., its Managing Member, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 4.4% | 5,994,810 | 0 | 5,994,810 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 4.4% | 5,994,810 | 0 | 5,994,810 | /s/ Phillip Gross | Phillip Gross, individually |